Detailed information for compound 229884

Basic information

Technical information
  • TDR Targets ID: 229884
  • Name: methyl 2-[[[5-(5-methyl-2,4-dioxopyrimidin-1- yl)-2,5-dihydrofuran-2-yl]methoxy-[4-(trifluo romethyl)phenoxy]phosphoryl]amino]propanoate
  • MW: 533.392 | Formula: C21H23F3N3O8P
  • H donors: 2 H acceptors: 4 LogP: 1.86 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 2
  • SMILES: COC(=O)C(NP(=O)(Oc1ccc(cc1)C(F)(F)F)OCC1C=CC(O1)n1cc(C)c(=O)[nH]c1=O)C
  • InChi: 1S/C21H23F3N3O8P/c1-12-10-27(20(30)25-18(12)28)17-9-8-16(34-17)11-33-36(31,26-13(2)19(29)32-3)35-15-6-4-14(5-7-15)21(22,23)24/h4-10,13,16-17H,11H2,1-3H3,(H,26,31)(H,25,28,30)
  • InChiKey: XSTNINKZHITLOZ-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • methyl 2-[[[5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methoxy-[4-(trifluoromethyl)phenoxy]phosphoryl]amino]propanoate
  • 2-[[[5-(5-methyl-2,4-dioxo-1-pyrimidinyl)-2,5-dihydrofuran-2-yl]methoxy-[4-(trifluoromethyl)phenoxy]phosphoryl]amino]propanoic acid methyl ester
  • 2-[[[5-(2,4-diketo-5-methyl-pyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methoxy-[4-(trifluoromethyl)phenoxy]phosphoryl]amino]propionic acid methyl ester

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis acetylcholinesterase 0.0134 0.7939 0.5611
Loa Loa (eye worm) hypothetical protein 0.0156 1 1
Brugia malayi metabotropic glutamate receptor subtype 5a (mGluR5a), putative 0.0115 0.6119 0.733
Loa Loa (eye worm) hypothetical protein 0.0134 0.7939 0.7939
Brugia malayi Metabotropic glutamate receptor precursor. 0.0127 0.7241 0.8977
Loa Loa (eye worm) carboxylesterase 0.0134 0.7939 0.7939
Loa Loa (eye worm) acetylcholinesterase 1 0.0134 0.7939 0.7939
Echinococcus granulosus carboxylesterase 5A 0.0134 0.7939 0.5611
Schistosoma mansoni metabotropic glutamate receptor 2 3 (mglur group 2) 0.0144 0.8878 1
Brugia malayi Carboxylesterase family protein 0.0134 0.7939 1
Brugia malayi Carboxylesterase family protein 0.0134 0.7939 1
Loa Loa (eye worm) hypothetical protein 0.0134 0.7939 0.7939
Echinococcus multilocularis carboxylesterase 5A 0.0134 0.7939 0.5611
Echinococcus granulosus acetylcholinesterase 0.0134 0.7939 0.5611
Echinococcus multilocularis metabotropic glutamate receptor 5 0.0156 1 1
Echinococcus granulosus acetylcholinesterase 0.0134 0.7939 0.5611
Schistosoma mansoni metabotropic glutamate receptor 0.0106 0.5304 0.5392
Loa Loa (eye worm) glutamate receptor 0.0127 0.7241 0.7241
Echinococcus multilocularis acetylcholinesterase 0.0134 0.7939 0.5611
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0134 0.7939 0.879

Activities

Activity type Activity value Assay description Source Reference
CC50 (functional) = 13 uM Cytostatic concentration required to inhibit CEM/0 cells proliferation by 50% ChEMBL. 10514282
EC50 (functional) = 0.01 uM Concentration required to protect CEM/0 cells against the cytopathicity of HIV-1 by 50% ChEMBL. 10514282
EC50 (functional) = 0.01 uM Concentration required to protect CEM/0 cells against the cytopathicity of HIV-2 by 50% ChEMBL. 10514282
EC50 (functional) = 0.018 uM Concentration required to protect CEM/TK cells against the cytopathicity of HIV-2 by 50% ChEMBL. 10514282
logD (ADMET) = 1.77 Partition coefficient (logD7.0) ChEMBL. 10514282
Selectivity index (functional) = 1300 Ratio CC50/EC50 for HIV-1 in CEM/0 cells ChEMBL. 10514282

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.